22nd Century Group (XXII) Misses Q4 EPS by 2c
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/14/2026
- S&P 500 ends lower as investors weigh data, Middle East tensions
- BofA's Hartnett explains why Wall Street is trading with 'no fear'
- Oil rises after US threatens indefinite blockade of Iran; set for weekly gains
- Are KOSPI and SOX in a bubble? Citi answers
- Could Intel return to the red-hot memory market after $20B raise and recent hire?
22nd Century Group Reports Business Highlights and Financial Results for the Fourth Quarter and Full-Year 2020
March 11, 2021 7:00 AM ESTKey Business and Financial Highlights
22nd Century has a tremendous global commercial opportunity in the more than $800 billion markets across the tobacco and hemp/cannabis industry.Securing Modified Risk Tobacco Product (MRTP) authorization for VLN® remains 22nd Centurys number one priority. The Company is highly confident that the FDA is in the final stages of the review process related to its application.22nd Century is fully prepared and eager to launch VLN® King and VLN® Menthol... More
